Depression and neurocognitive performance in individuals with HIV/AIDS: 2‐year follow‐up
- 18 January 2006
- journal article
- Published by Wiley in HIV Medicine
- Vol. 7 (2), 112-121
- https://doi.org/10.1111/j.1468-1293.2006.00350.x
Abstract
The aims of this study were to follow a cohort of HIV-infected individuals for 2 years to assess changes in depression and neuropsychological performance over time, to explore the relationship between depression, HIV illness and neuropsychological performance, and to examine the natural history of the effect of highly active antiretroviral therapy (HAART) on depression and neurocognitive performance. HIV-seropositive out-patients were assessed at baseline and at 2-year follow-up. At each assessment, patients were assessed for depression [using the Beck Depression Inventory (BDI) and Structured Clinical Interview (SCID-CV)] and completed a battery of neuropsychological tests including the Cambridge Neuropsychological Test Automated Battery (CANTAB) and the Hopkins HIV Dementia Scale (HDS). At baseline, 34.8% scored > or =14 on the BDI [> or =14 suggests depressive symptoms (DS)]. The SCID-CV revealed that 27% of participants met the criteria for current mood disorder. Seven per cent of the participants' scores on the HDS indicated HIV-associated cognitive changes. Eighty participants were re-tested at 2-year follow-up and were split into two groups based on BDI scores at baseline. CANTAB results revealed that the cohort were significantly impaired on nine of 10 measures compared with age-matched normative data. Neurocognitive performance significantly improved for participants with no DS at baseline, whereas participants with DS at baseline did not show as much improvement. Multivariate analysis revealed that 40% of the change in cognitive performance was attributable to the variables age, AIDS and HAART regimen. These results suggest a significant decline in depression scores and an improvement in several neurocognitive domains over time, with a relationship between HIV illness, HAART, symptoms of depression and neurocognitive performance.Keywords
This publication has 25 references indexed in Scilit:
- Influence of depressed mood on neuropsychologic performance in HIV-seropositive drug usersPsychiatry and Clinical Neurosciences, 2003
- The Prevalence of Distress in Persons With Human Immunodeficiency Virus InfectionPsychosomatics, 2002
- Depressive symptoms reduced in individuals with HIV/AIDS treated with highly active antiretroviral therapy: a longitudinal studyAustralian & New Zealand Journal of Psychiatry, 2000
- Neurocognitive Complaints in HIV-Infection and Their Relationship to Depressive Symptoms and Neuropsychological FunctioningJournal of Clinical and Experimental Neuropsychology, 1999
- Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapyAIDS, 1999
- The impact of HIV-related neuropsychological dysfunction on driving behaviorJournal of the International Neuropsychological Society, 1999
- Anxiety and depression among hiv-infected heterosexuals— a report from indiaJournal of Psychosomatic Research, 1998
- WHO Neuropsychiatric AIDS Study, Cross-sectional Phase IArchives of General Psychiatry, 1994
- Mortality risks in gay men with human immunodeficiency virus infection and cognitive impairmentNeurology, 1993
- The AIDS dementia complex: I. Clinical featuresAnnals of Neurology, 1986